All News

Expanding the Obesity Treatment Toolbox: The Promise of Dual-Action Medications
November 21, 2024

Michael Crotty, MD, an expert in obesity medicine, discusses GLP-1RAs in the context of weight loss, including the novel dual agonist survodutide.

FDA Clears Phase 2 Study of Cannabis for PTSD Treatment in Veterans
November 21, 2024

After a 3-year negotiation, the FDA has cleared a phase 2 clinical trial assessing the use of smoked cannabis for the treatment of PTSD symptoms in veterans.

Dupilumab, Ensifentrine Added to 2025 GOLD Guidelines for COPD: Expert Parses Recommendations
November 21, 2024

Professor MeiLan Han, MD, MS, details inclusion of the 2 new medications and how the additions reflect a focus on disease heterogeneity and precision medicine in in COPD.

Sharp Rise in Early-Onset Colorectal Cancer Mortality Among Young US Adults: Daily Dose
November 21, 2024

Your daily dose of the clinical news you may have missed.

More than Half of US Adults May Be Eligible for Semaglutide Therapy, Accordng to New Estimates
November 21, 2024

Millions of US adults could benefit from semaglutide treatment for diabetes, obesity, and/or CV disease but insurance isn't guaranteed and the drug is costly.

New UTI Guideline Offers Treatment Clarity, but Reveals Pressing Gaps in Research
November 20, 2024

The recommendations from WikiGuidelines are the first for UTI prevention, diagnosis, and management in over a decade.

Antivirals for Influenza Underutilized Among Vulnerable Children, Adolescents
November 20, 2024

Analysis of surveillance data revealed a decline in use of antiviral medications for children hospitalized with influenza and prevalent underprescribing in outpatient settings.

Treatment for Agitation in Alzheimer Dementia: Pipeline Preview with George Grossberg, MD
November 20, 2024

"It's a very rich pipeline because [agitation] is a very common and very debilitating symptom in Alzheimer's disease," Grossberg observed.

Metabolic Bariatric Surgery Takes a Backseat as GLP-1RA Use Rises: Daily Dose
November 20, 2024

Your daily dose of the clinical news you may have missed.

Exercise of Any Level Linked to Reduced All-Cause Mortality in Individuals with Dementia
November 19, 2024

Physical activity of any level before and after a diagnosis of dementia was associated with at least a 20% lower risk for all-cause mortality across dementia subtypes.